Blogs about: Dopamine D2
Featured Blog
FDA approves AstraZeneca’s Seroquel XR for the Treatment of Bipolar Depression and Bipolar Mania
The US FDA has approved AstraZeneca’s Seroquel XR for the Treatment of Bipolar Depression and Bipolar Mania in the US… more →
GPCR News
FDA approves AstraZeneca’s Seroquel XR for the Treatment of Bipolar Depression and Bipolar Mania
crimsoncanary wrote 1 year ago: The US FDA has approved AstraZeneca’s Seroquel XR for the Treatment of Bipolar Depression and Bipola … more →
Forest/Gedeon Richters Cariprazine effective in Acute Mania Associated with Bipolar I Disorder
crimsoncanary wrote 1 year ago: Forest Laboratories and Gedeon Richter have announced results from a phase II clinical trial of car … more →
Alexza initiate 2nd phase III trial of AZ-004 in schizophrenia/bipolar disorder
crimsoncanary wrote 1 year ago: Alexza has initiated a second Phase III trial of AZ-004 (Staccato, loxapine) for the treatment of ac … more →
Vanda receive non approvable letter for Iloperidone
crimsoncanary wrote 1 year ago: Vanda Pharmaceuticals have received a not approvable letter from the US FDA for iloperidone, an atyp … more →
FDA approves first generic risperidone
crimsoncanary wrote 1 year ago: The FDA has approved the first generic versions of Risperdal (risperidone) tablets, manufactured by … more →
Acadias ACP-104 does not meet endpoint in Phase IIb Schizophrenia trial
crimsoncanary wrote 1 year ago: Acadia’s ACP-104 did not meet its primary endpoint of antipsychotic efficacy in a Phase IIb Sc … more →
FDA approves GSKs Requip XL for Parkinsons
crimsoncanary wrote 1 year ago: The FDA has approved GSKs extended release formulation of Requip (ropinirole) for the treatment of t … more →
Jazz cut research staff and update on portfolio
crimsoncanary wrote 1 year ago: Jazz Pharmaceuticals have announced that they will be reducing their workforce by 33 employees and w … more →
AstraZeneca submit European application for Seroquel XR in the treatment of Major Depressive Disorder
crimsoncanary wrote 1 year ago: AstraZeneca have submitted a European application for Seroquel (quetiapine fumarate) extended releas … more →
Axxonis submit MAA for Nedad (lisuride) transdermal patch and s.c. infusion
crimsoncanary wrote 1 year ago: Axxonis Pharma have submitted a MAA for: - Nenad lisuride transdermal patch for the add on treatment … more →
Seroquel approved for Maintenance Treatment in Bipolar Disorder
crimsoncanary wrote 1 year ago: The FDA has approved Seroquel (quetiapine fumarate) for the maintenance treatment of patients with b … more →
First generic Ropinirole approved by FDA
crimsoncanary wrote 1 year ago: The FDA has approved the first generic versions of Requip (ropinirole hydrochloride) tablets for the … more →
Aripiprazole approved for two more indications
crimsoncanary wrote 1 year ago: The Fda has approved Abilify (aripiprazole) for two more indications: - As a maintenance Treatment i … more →
Schering-Plough present data on Asenapine at APA meeting
crimsoncanary wrote 1 year ago: Asenapine, under development for schizophrenia and bipolar I disorder, has been shown to be effectiv … more →
AstraZeneca submit sNDA for Seroquel XR in GAD
crimsoncanary wrote 1 year ago: AstraZeneca have submitted a supplemental NDA for Seroquel XR for the Treatment of Generalised Anxie … more →
Iloperidone shows efficacy in Phase III trial
crimsoncanary wrote 1 year ago: Vanda Pharmaceutical’s 5HT2A/D2 antagonist has demonstrated efficacy with low rates of movemen … more →
